Glucose, insulin, and insulin resistance in normal-weight, overweight and obese children with obstructive sleep apnea

正常体重、超重和肥胖儿童阻塞性睡眠呼吸暂停的葡萄糖、胰岛素和胰岛素抵抗

阅读:1

Abstract

BACKGROUND: Obstructive sleep apnea (OSA) is associated with components of metabolic syndrome. Both body weight and OSA independently influence metabolic measurements. The goal of this study was to determine whether OSA in normal-weight, overweight or obese children, compared to matched control groups, was associated with increased levels of glucose, insulin and insulin resistance (IR). METHODS: Age- and gender-specific body mass index (BMI) percentiles were determined and used to categorize subjects into normal-weight (BMI<85%) and overweight-obese (BMI≥85%) groups. In addition, subjects were divided into normal-weight (BMI<85%), overweight (BMI≥85% and <95%) and obese (BMI≥95%) groups. Polysomnography was conducted and morning levels of glucose and insulin were measured and IR was determined from the blood samples collected early in the morning after overnight fast. Results were compared between the subject groups. Effects of severity of OSA defined by apnea hypopnea index (AHI) and oxygen desaturation index (ODI) on glucose, insulin, and HOMA-IR were analyzed. RESULTS: Glucose, insulin, and HOMA-IR in OSA and matched control groups were not significantly different for normal-weight, overweight and obese subjects. The ODI was significantly associated with elevated levels of glucose and HOMA-IR after adjustment for age, gender, race, and BMI Z-score. CONCLUSIONS: IR levels between OSA and control for both normal-weight, overweight and obese subjects were not significantly different. The ODI was associated with increased IR in children with OSA. OSA-induced hypoxic events during sleep may be a potential mechanism of increased IR in children with OSA, independent of body weight.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。